USE OF ANTIBODIES AND FACTOR-IX VARIANTS IN PROBING CONFORMATIONAL TRANSITIONS IN THE PROTEASE DOMAIN OF FACTOR-IX

被引:0
|
作者
BAJAJ, SP
SABHARWAL, K
GORKA, J
BIRKTOFT, JJ
机构
[1] ST LOUIS UNIV,SCH MED,ST LOUIS,MO 63104
[2] WASHINGTON UNIV,SCH MED,ST LOUIS,MO 63110
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:749 / 749
页数:1
相关论文
共 50 条
  • [1] MONOCLONAL-ANTIBODIES TO FACTOR-IX - CHARACTERIZATION AND USE IN IMMUNOASSAYS FOR FACTOR-IX
    SMITH, KJ
    ONO, K
    THROMBOSIS RESEARCH, 1984, 33 (02) : 211 - 224
  • [2] MOLECULAR DEFECTS IN FACTOR-IX KAWACHINAGANO, FACTOR-IX KASHIHARA AND FACTOR-IX NIIGATA
    YOSHIOKA, A
    THROMBOSIS AND HAEMOSTASIS, 1989, 62 (01) : 464 - 464
  • [3] HETEROGENEITY OF FACTOR-IX IN THERAPEUTIC FACTOR-IX CONCENTRATES
    MENACHE, D
    ARONSON, DL
    THROMBOSIS RESEARCH, 1978, 13 (05) : 821 - 828
  • [4] MISSENSE MUTATIONS IN FACTOR-IX KASHIHARA AND FACTOR-IX NIIGATA
    NISHIMURA, T
    NAKA, H
    KUZE, K
    MORIMOTO, H
    SUGIMOTO, M
    SAKAI, T
    MIKAMI, S
    YOSHIOKA, A
    FUKUI, H
    TSUJIMOTO, A
    HASHIMOTOGOTHO, T
    ACTA HAEMATOLOGICA JAPONICA, 1990, 53 (06): : 1030 - 1035
  • [5] STANDARDIZATION OF FACTOR-IX - STANDARDS FOR PURIFIED FACTOR-IX CONCENTRATES
    LAMB, MA
    FRICKE, WA
    RASTOGI, SC
    THROMBOSIS AND HAEMOSTASIS, 1991, 66 (05) : 548 - 551
  • [6] DETERMINATION OF THE RELATIVE ACTIVITIES OF 2 FACTOR-IX VARIANTS - FACTOR-IX ALABAMA AND FACTOR-IX CHAPEL HILL - IN A PURIFIED FACTOR-X ACTIVATING SYSTEM
    BRIET, E
    GRIFFITH, MJ
    BRAUNSTEIN, KM
    ROBERTS, HR
    FEDERATION PROCEEDINGS, 1982, 41 (03) : 656 - 656
  • [7] THE USE OF RFVIIA TO TREAT A FACTOR-IX INHIBITOR FOLLOWING ANAPHYLAXIS WITH FACTOR-IX CONCENTRATE
    COLLINS, PW
    FIELDS, P
    GOLDMAN, E
    LEE, CA
    PASI, KJ
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1029 - 1029
  • [8] RADIOIMMUNOASSAY FOR ANTIBODIES TO HUMAN FACTOR-IX
    LEWIS, RM
    REISNER, HM
    CHUNG, KS
    ROBERTS, HR
    FEDERATION PROCEEDINGS, 1979, 38 (03) : 1410 - 1410
  • [9] HETEROGENEITY OF FACTOR-IX BM DIFFERENCE OF CLEAVAGE SITES BY FACTOR-XIA AND CA-2+ IN FACTOR-IX KASHIHARA, FACTOR-IX NAGOYA AND FACTOR-IX NIIGATA
    YOSHIOKA, A
    OHKUBO, Y
    NISHIMURA, T
    TANAKA, I
    FUKUI, H
    OGATA, K
    KAMIYA, T
    TAKAHASHI, H
    THROMBOSIS RESEARCH, 1986, 42 (05) : 595 - 604
  • [10] CONFORMATION OF THE PROPEPTIDE DOMAIN OF FACTOR-IX
    CHENG, JW
    CHEN, CP
    HUANG, TH
    CHOU, SH
    CHEN, SH
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 1995, 1245 (02): : 227 - 231